Insider · CIK 0001207131
Thomas C Hutton
officerdirector
Files at CHE (CHEMED CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | CHE CHEMED CORP | MOption exercise Capital Stock | +4,629 | $445.35 | $2.1M | 37,110 | 13 d ago |
| Sep 28, 2026 | CHE CHEMED CORP | FTax withholding Capital Stock | -4,270 | $506.65 | $2.2M | 32,840 | 13 d ago |
| Sep 28, 2026 | CHE CHEMED CORP | MOption exercise Stock Option (right to buy with tandem tax withholding)derivative | -4,629 | $445.35 | $2.1M | 22,089 | 13 d ago |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +315 | $553.39 | $174k | 33,080 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +96 | $553.39 | $53k | 33,176 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | FTax withholding Capital Stock | -149 | $553.39 | $82k | 33,027 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Performance Stock Unitsderivative | -156 | $0.00 | $0 | 770 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Performance Stock Unitsderivative | -156 | $0.00 | $0 | 614 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | AGrant or award Performance Stock Unitsderivative | +320 | $0.00 | $0 | 934 | Feb 18, 2025 |
| Oct 22, 2024 | CHE CHEMED CORP | AGrant or award Stock Option (right to buy with tandem tax withholding)derivative | +4,523 | $597.70 | $2.7M | 20,380 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.